Factors | No. of patients | VEGF | ||
---|---|---|---|---|
Positive expression | χ2 | P | ||
Age | ||||
<60 | 24 | 14(58.3%) | 0.059 | 0.809 |
≥ 60 | 47 | 26(55.3%) | ||
Sex | ||||
Male | 43 | 25(58.1%) | 0.144 | 0.704 |
Female | 28 | 15(53.6%) | ||
Tumor size | ||||
<5 cm | 31 | 19(61.3%) | 0.549 | 0.459 |
≥ 5 cm | 40 | 21(52.5%) | ||
Differentiation grade | ||||
Poor | 11 | 4(36.4%) | 5.431 | 0.066 |
Moderate | 48 | 26(54.2%) | ||
Well | 12 | 10(83.3%) | ||
Invasion Depth | ||||
T1 + T2 | 10 | 5(50%) | 0.190 | 0.663 |
T3 + T4 | 61 | 35(57.4%) | ||
Tumor stage | ||||
I+II | 42 | 12(28.6%) | 32.229 | <0.001 |
III+IV | 29 | 28(96.6%) | ||
lymphnode matastasis, | ||||
No | 44 | 14(31.8%) | 28.280 | <0.001 |
Yes | 27 | 26(96.3%) | ||
Liver matastasis | ||||
NO | 60 | 30(50%) | 6.324 | 0.012 |
Yes | 11 | 10(90.9%) |